Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

Merck & Co (NYSE:MRK) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Merck & Co (MRK) operate in?

Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	308.00 / 8.34M
Day Range	- - -
52 Wk Range	99.14 - 134.63
Market Cap	$324.78B
P/E Ratio	141.91
Dividend Yield	2.41%
Exchange	NYSE
RSI	48
Short Interest	0.77%
Days to Cover	2.87

Recent News

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens the door to a more personalized and effective treatment as messenger RNA instructs the patient’s cells how to combat diseases like cancer.

Upwallstreet

5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024

Ten of the Dow Jones Industrial Average stocks were up double digit percentage in the first half of 2024. A look at the best and worst performers.

Chris Katje

What's Going On With Merck Stock On Monday?

Merck secures exclusive global rights to develop and commercialize opevesostat (MK-5684/ODM-208) for hormone-dependent cancers. Orion is eligible for milestone payments up to $1.63 billion and tiered royalties.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Merck & Co Inc

Sector

Health Care

Industry

Pharmaceuticals

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, in...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Merck & Co (MRK) stock?

You can purchase shares of Merck & Co (NYSE:MRK) through any online brokerage.

View our list of the best stock brokerages

Who are Merck & Co (MRK) competitors?

Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).

What is the target price for Merck & Co (MRK) stock?

There is no analysis for Merck & Co.

What is the forecast for Merck & Co (MRK) stock?

Merck & Co has a consensus price target of $120.37.

Current stock price for Merck & Co (MRK)?

The stock price for Merck & Co (NYSE: MRK) is $128.23 last updated Today at July 3, 2024 at 5:16 AM EDT.

Does Merck & Co (MRK) pay a dividend?

A quarterly cash dividend of 0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on July 8, 2024 to stockholders of record on June 17, 2024.

When is Merck & Co (NYSE:MRK) reporting earnings?

Merck & Co’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Is Merck & Co (MRK) going to split?

There is no upcoming split for Merck & Co.

What sector and industry does Merck & Co (MRK) operate in?

Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Merck & Co

Merck & Co (MRK) Forecast